
[D-Cys 14 ]-Somatostatin is the first analog of somatostatin found to be more potent in inhibiting glucagon and growth hormone secretion than it is in inhibiting insulin secretion. [D-Trp 8 ]-Somatostatin is eight to ten times more potent than somatostatin in inhibiting insulin, glucagon, and growth hormone secretion. [D-Trp 8 ,D-Cys 14 ]-Somatostatin is more potent than [D-Cys 14 ]-somatostatin, but retains its relative selectivity in being a more potent inhibitor of the secretion of glucagon and growth hormone than of insulin.
Blood Glucose, Male, Portal Vein, In Vitro Techniques, Glucagon, Rats, Structure-Activity Relationship, Pituitary Gland, Anterior, Growth Hormone, Insulin Secretion, Animals, Insulin, Biological Assay, Somatostatin
Blood Glucose, Male, Portal Vein, In Vitro Techniques, Glucagon, Rats, Structure-Activity Relationship, Pituitary Gland, Anterior, Growth Hormone, Insulin Secretion, Animals, Insulin, Biological Assay, Somatostatin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 145 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
